GB0812641D0 - Compounds - Google Patents

Compounds

Info

Publication number
GB0812641D0
GB0812641D0 GBGB0812641.9A GB0812641A GB0812641D0 GB 0812641 D0 GB0812641 D0 GB 0812641D0 GB 0812641 A GB0812641 A GB 0812641A GB 0812641 D0 GB0812641 D0 GB 0812641D0
Authority
GB
United Kingdom
Prior art keywords
compounds
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB0812641.9A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Prosidion Ltd
Original Assignee
Prosidion Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Prosidion Ltd filed Critical Prosidion Ltd
Priority to GBGB0812641.9A priority Critical patent/GB0812641D0/en
Publication of GB0812641D0 publication Critical patent/GB0812641D0/en
Priority to PCT/GB2009/050828 priority patent/WO2010004345A1/en
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
GBGB0812641.9A 2008-07-10 2008-07-10 Compounds Ceased GB0812641D0 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
GBGB0812641.9A GB0812641D0 (en) 2008-07-10 2008-07-10 Compounds
PCT/GB2009/050828 WO2010004345A1 (en) 2008-07-10 2009-07-10 Piperidinyl gpcr agonists

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB0812641.9A GB0812641D0 (en) 2008-07-10 2008-07-10 Compounds

Publications (1)

Publication Number Publication Date
GB0812641D0 true GB0812641D0 (en) 2008-08-20

Family

ID=39722067

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB0812641.9A Ceased GB0812641D0 (en) 2008-07-10 2008-07-10 Compounds

Country Status (2)

Country Link
GB (1) GB0812641D0 (en)
WO (1) WO2010004345A1 (en)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0904287D0 (en) 2009-03-12 2009-04-22 Prosidion Ltd Compounds for the treatment of metabolic disorders
GB0904284D0 (en) 2009-03-12 2009-04-22 Prosidion Ltd Compounds for the treatment of metabolic disorders
GB0904285D0 (en) 2009-03-12 2009-04-22 Prosidion Ltd Compounds for the treatment of metabolic disorders
TW201111361A (en) 2009-06-24 2011-04-01 Boehringer Ingelheim Int New compounds, pharmaceutical composition and methods relating thereto
JP2012530758A (en) 2009-06-24 2012-12-06 ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング Novel compounds, pharmaceutical compositions and methods relating thereto
EP2547339A1 (en) 2010-03-18 2013-01-23 Boehringer Ingelheim International GmbH Combination of a gpr119 agonist and the dpp-iv inhibitor linagliptin for use in the treatment of diabetes and related conditions
GB201006166D0 (en) 2010-04-14 2010-05-26 Prosidion Ltd Compounds for the treatment of metabolic disorders
GB201006167D0 (en) 2010-04-14 2010-05-26 Prosidion Ltd Compounds for the treatment of metabolic disorders
TW201209054A (en) 2010-05-28 2012-03-01 Prosidion Ltd Novel compounds
US8530413B2 (en) 2010-06-21 2013-09-10 Sanofi Heterocyclically substituted methoxyphenyl derivatives with an oxo group, processes for preparation thereof and use thereof as medicaments
TW201221505A (en) 2010-07-05 2012-06-01 Sanofi Sa Aryloxyalkylene-substituted hydroxyphenylhexynoic acids, process for preparation thereof and use thereof as a medicament
TW201215388A (en) 2010-07-05 2012-04-16 Sanofi Sa (2-aryloxyacetylamino)phenylpropionic acid derivatives, processes for preparation thereof and use thereof as medicaments
TW201215387A (en) 2010-07-05 2012-04-16 Sanofi Aventis Spirocyclically substituted 1,3-propane dioxide derivatives, processes for preparation thereof and use thereof as a medicament
AR083904A1 (en) 2010-11-18 2013-04-10 Prosidion Ltd DERIVATIVES OF DISPOSED 1,4-PIRROLIDINS AND 3-IL-AMINAS AND THEIR USES IN THE TREATMENT OF METABOLIC DISORDERS
GB201114389D0 (en) 2011-08-22 2011-10-05 Prosidion Ltd Novel compounds
KR20140045440A (en) 2011-06-30 2014-04-16 제넨테크, 인크. Anti-c-met antibody formulations
WO2013037390A1 (en) 2011-09-12 2013-03-21 Sanofi 6-(4-hydroxy-phenyl)-3-styryl-1h-pyrazolo[3,4-b]pyridine-4-carboxylic acid amide derivatives as kinase inhibitors
WO2013045413A1 (en) 2011-09-27 2013-04-04 Sanofi 6-(4-hydroxy-phenyl)-3-alkyl-1h-pyrazolo[3,4-b]pyridine-4-carboxylic acid amide derivatives as kinase inhibitors
JP2014533700A (en) 2011-11-21 2014-12-15 ジェネンテック， インコーポレイテッド Purification of anti-c-MET antibody
AU2019213484A1 (en) * 2018-02-05 2020-07-02 Centre National De La Recherche Scientifique Compounds and compositions for the treatment of pain

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20100063081A1 (en) * 2005-06-30 2010-03-11 Stuart Edward Bradly CPCR Agonists
PE20081659A1 (en) * 2007-01-04 2008-10-24 Prosidion Ltd GPCR AGONISTS
EP2114936A1 (en) * 2007-01-04 2009-11-11 Prosidion Limited Piperidine gpcr agonists

Also Published As

Publication number Publication date
WO2010004345A1 (en) 2010-01-14

Similar Documents

Publication Publication Date Title
GB0807862D0 (en) Compounds
GB0800035D0 (en) Compounds
GB0812649D0 (en) Compounds
GB0812641D0 (en) Compounds
GB0804702D0 (en) Compounds
GB0809776D0 (en) Compounds
GB0807103D0 (en) Compounds
GB0800367D0 (en) Compounds
GB0807910D0 (en) Compounds
GB0801220D0 (en) Compounds
GB0801265D0 (en) Compounds
GB0811029D0 (en) Compounds
GB0809771D0 (en) Compounds
GB0802192D0 (en) Compounds
GB0802231D0 (en) Compounds
GB0802586D0 (en) Compounds
GB0802587D0 (en) Compounds
GB0803493D0 (en) Compounds
GB0806083D0 (en) Compounds
GB0812622D0 (en) Compounds
GB0811450D0 (en) Compounds
GB0803495D0 (en) Compounds
GB0811449D0 (en) Compounds
GB0811203D0 (en) Compounds
GB0801596D0 (en) Compounds

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)